tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andrew Paine, 3 are a BUY (100%).
Analyst Andrew Paine, currently employed at CLSA,
Andrew Paine’s has documented 8 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RMD, ResMed at 14-Oct-2022.
Analyst best performing recommendations are on RMD (RESMED).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 06-Aug-2026
$262
$32.56 (14.19%)
$244
Buy Since 05-Feb-2024
$267
$37.56 (16.37%)
$255
16 days ago
(30-Aug-2026)
7/13 (53.85%)
$26.9 (11.20%)
142
Hold Since 12-Oct-2025
$215
$-14.44 (-6.29%)
$225
1 months 9 days ago
(06-Aug-2026)
4/5 (80%)
$3.06 (1.44%)
39
Hold Since 09-Jan-2025
$225
$-4.44 (-1.94%)
$275
1 months 9 days ago
(06-Aug-2026)
5/5 (100%)
$13.06 (6.16%)
46
Buy Since 13-Apr-2023
$220
$-9.44 (-4.11%)
$300
2 months 1 days ago
(14-Jul-2026)
16/17 (94.12%)
$21.43 (10.79%)
107
What Year was the first public recommendation made by Andrew Paine?
